DB17650InvestigationalCell transplant therapies
AVR-RD-02 is an investigational ex vivo lentiviral gene therapy developed by AVROBIO Inc. It consists of autologous CD34+ enriched hematopoietic stem cells (HSCs) that have been genetically modified ex vivo... AVR-RD-02 is being investigated in Gaucher Disease.
- Code names
- AVR-RD-02
What you can answer from here — as of April 23, 2025
Which companies are running trials of AVR-RD-02, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account